Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-29 @ 4:17 PM
Study NCT ID:
NCT06092606
Status:
UNKNOWN
Last Update Posted:
2023-10-23
First Post:
2023-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Sponsor:
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-09
First Submit QC Date:
None
Study First Post Date:
2023-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-20
Last Update Post Date:
2023-10-23
Last Update Post Date Type:
ACTUAL